Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,629,000 | 6,467,000 | 5,175,000 | 5,524,000 | 7,257,000 |
| Marketable Securities | 42,000 | 0 | 1,000 | 31,000 | 28,000 |
| Receivables | 12,769,000 | 12,637,000 | 12,477,000 | 10,919,000 | 11,472,000 |
| Inventories | 4,938,000 | 4,960,000 | 4,526,000 | 4,181,000 | 4,450,000 |
| TOTAL | $28,539,000 | $29,261,000 | $27,675,000 | $25,582,000 | $27,785,000 |
| Non-Current Assets | |||||
| PPE Net | 5,483,000 | 5,283,000 | 5,237,000 | 5,134,000 | 5,141,000 |
| Investments And Advances | 291,000 | 310,000 | 287,000 | 279,000 | 267,000 |
| Intangibles | 89,941,000 | 92,669,000 | 93,774,000 | 95,024,000 | 101,941,000 |
| Other Non-Current Assets | 9,644,000 | 9,659,000 | 9,192,000 | 9,142,000 | 8,288,000 |
| TOTAL | $105,359,000 | $107,921,000 | $108,490,000 | $109,579,000 | $115,637,000 |
| Total Assets | $133,898,000 | $137,182,000 | $136,165,000 | $135,161,000 | $143,422,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,772,000 | 7,522,000 | 5,362,000 | 6,804,000 | 12,570,000 |
| Accounts payable and accrued liabilities | 33,619,000 | 32,245,000 | 31,041,000 | 31,945,000 | 30,492,000 |
| TOTAL | $39,391,000 | $39,767,000 | $36,403,000 | $38,749,000 | $43,062,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 62,971,000 | 62,959,000 | 64,527,000 | 60,340,000 | 58,509,000 |
| Other Non-Current Liabilities | 31,653,000 | 32,037,000 | 31,188,000 | 30,130,000 | 33,028,000 |
| TOTAL | $97,106,000 | $97,553,000 | $98,300,000 | $93,048,000 | $94,289,000 |
| Total Liabilities | $136,497,000 | $137,320,000 | $134,703,000 | $131,797,000 | $137,351,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,767,385 | 1,766,558 | 1,766,403 | 1,765,355 | 1,767,140 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | -14,234,000 | -11,503,000 | -9,527,000 | -7,900,000 | -4,964,000 |
| Other shareholders' equity | -1,531,000 | -1,493,000 | -1,700,000 | -1,886,000 | -2,295,000 |
| TOTAL | $-2,599,000 | $-138,000 | $1,462,000 | $3,364,000 | $6,071,000 |
| Total Liabilities And Equity | $133,898,000 | $137,182,000 | $136,165,000 | $135,161,000 | $143,422,000 |